Four things to know:
1. A Delaware vice chancellor made the ruling Feb. 14, which compels a testimony from Mr. Serota, who is a nonparty in the case.
2. The ruling follows a Cigna motion to require Mr. Serota to appear at the trial. In that motion, Cigna argued that Mr. Serota could offer testimony on its claims that Anthem didn’t use reasonable best efforts to address antitrust concerns.
3. In February 2017, Cigna sued Anthem in Chancery Court for a termination fee, damages and costs related to the failed deal, which is estimated at $15 billion. Anthem then sued Cigna in May 2017 for about $20 billion in damages and costs.
4. The trial is set to begin Feb. 25, according to Law 360.
More articles on payer issues:
Humana CFO says Trump’s drug proposal will raise premiums
Utah may unwind voter-approved Medicaid expansion
UnitedHealth updates opioid policy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
